Understanding BI-RADS Category 3
RadioGraphics · 01.01.2025 · 45 (1)
DOI: 10.1148/rg.240169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RadioGraphics, erschienen am 01.01.2025. Verfasst von Soudabeh Fazeli und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology, Division of Breast Imaging, UC San Diego Health, Koman Family Outpatient Pavilion, 9400 Campus Point Dr, #7316, La …. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammography, Magnetic Resonance Imaging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BI-RADS category 3 is used for findings with a low malignancy probability and warrants careful short-interval follow-up imaging, and misconceptions about category 3 and new data supporting its use in breast MRI highlight the need for continued education on appropriate use in multimodality breast imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Radiology, Division of Breast Imaging, UC San Diego Health, Koman Family Outpatient Pavilion, 9400 Campus Point Dr, #7316, La Jolla, CA 92037 (S.F., J.S., R.R.P., H.O.F.); and Department of Breast…
ORCID-Profile: Soudabeh Fazeli, Mary S Guirguis, Beatriz Adrada, Rebecca Rakow-Penner, Haydee Ojeda-Fournier
Förderung
- NCI NIH HHS
Zitieren
APA
Fazeli, S., Stepenosky, J., Guirguis, M. S., Adrada, B., Rakow-Penner, R., & Ojeda-Fournier, H. (2025). Understanding BI-RADS Category 3. RadioGraphics, 45(1). https://doi.org/10.1148/rg.240169
Vancouver
Fazeli S, Stepenosky J, Guirguis MS, Adrada B, Rakow-Penner R, Ojeda-Fournier H. Understanding BI-RADS Category 3. RadioGraphics. 2025;45(1). doi:10.1148/rg.240169
BibTeX
@article{Fazeli2025,
author = {Fazeli, Soudabeh and Stepenosky, James and Guirguis, Mary S and Adrada, Beatriz and Rakow-Penner, Rebecca and Ojeda-Fournier, Haydee},
title = {Understanding BI-RADS Category 3},
journal = {RadioGraphics},
year = {2025},
volume = {45},
number = {1},
doi = {10.1148/rg.240169}
}
EUVIMED